Braeburn Pharmaceuticals (Princeton, N.J.). Braeburn Pharmaceuticals is a commercial stage pharmaceutical company focused on care for underserved populations. Its first product, Probuphine, treats opioid addiction. The company’s culture is built on mutual respect and encourages outside-the-box thinking, with team members rewarded for individual contributions and meeting team goals. The company’s CEO, Behshad Sheldon, has grown the company from a handful of employees in 2014 to more than 100 employees today. In February 2017, Fast Company named Braeburn one of the top 10 “Most Innovative Companies in Biotech.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.